The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Therapy of the Hypereosinophilic Syndrome
Abstract
Previous studies of patients with the hypereosinophilic syndrome have found very significant morbidity and a high mortality of 77% at 3 years. Our study analyzes the therapy and prognosis of 26 patients with the hypereosinophilic syndrome. Five patients showed no evidence of progressive organ-system dysfunction and were given no therapy; all have done well. Sixteen patients with progressive organ dysfunction were treated with corticosteroids; six of the 16 had a good response and needed no further therapy. Five patients were treated with various chemotherapeutic agents that proved to be ineffective. In eight patients who were unresponsive to corticosteroid therapy, hydroxyurea produced excellent responses in six and partial responses in two. With the above regimen, our 26 patients (including 12 with poor prognostic indicators) have had a marked increase in survival (3-year mortality of 4%) when compared with the historical control group.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature.
Chusid, M. J., Dale, D. C., West, B. C., & Wolff, S. M. (1975) · PubMed · Cited by 1,233
Self-citationTHE HYPEREOSINOPHILIC SYNDROME: Analysis of Fourteen Cases With Review of The Literature
CHUSID, M. J., DALE, D. C., WEST, B. C., & WOLFF, S. M. (1975) · Medicine · doi:10.1097/00005792-197501000-00001 · Cited by 1,078
Self-citationThe Hypereosinophilic Syndromes
HARDY, W. R., & ANDERSON, R. E. (1968) · Annals of Internal Medicine · doi:10.7326/0003-4819-68-6-1220 · Cited by 490
Endomyocardial disease and eosinophilia
Roberts, W. C., Liegler, D. G., & Carbone, P. P. (1969) · The American Journal of Medicine · doi:10.1016/0002-9343(69)90055-2 · Cited by 155
Benvenisti, D., & ULTMANN, J. E. (1969) · Annals of Internal Medicine · doi:10.7326/0003-4819-71-4-731 · Cited by 139
Eosinophilic Leukemia and Disseminated Eosinophilic Collagen Disease — a Disease Entity?
Odeberg, B. (1965) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1965.tb01815.x · Cited by 91
Fibroplastic parietal endocarditis with eosinophilia
Brink, A. J., & Weber, H. W. (1963) · The American Journal of Medicine · doi:10.1016/0002-9343(63)90038-x · Cited by 70
Endomyocardiopathy With Eosinophilia
Solley, G. O., Maldonado, J. E., Gleich, G. J., Giuliani, E. R., Hoagland, H. C., Pierre, R. V., & Brown, J. A. L. (1976) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(25)05197-3 · Cited by 58
Resnick, M. E., & Myerson, R. M. (1971) · The American Journal of Medicine · doi:10.1016/0002-9343(71)90262-2 · Cited by 23
Cited by
The idiopathic hypereosinophilic syndrome
Weller, P., & Bubley, G. (1994) · Blood · doi:10.1182/blood.v83.10.2759.2759 · Cited by 929
Rothenberg, M. E. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805283382206 · Cited by 834
FAUCI, A. S., HARLEY, J. B., ROBERTS, W. C., FERRANS, V. J., GRALNICK, H. R., & BJORNSON, B. H. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-1-78 · Cited by 823
Self-citationParaneoplastic Syndromes: An Approach to Diagnosis and Treatment
Pelosof, L. C., & Gerber, D. E. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0099 · Cited by 773
Mechanisms of Glucocorticoid Action on Immune Processes
Parrillo, J. E., & Fauci, A. S. (1979) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.19.040179.001143 · Cited by 405
Self-citationKlion, A. D., Noel, P., Akin, C., Law, M. A., Gilliland, D. G., Cools, J., Metcalfe, D. D., & Nutman, T. B. (2003) · Blood · doi:10.1182/blood-2003-01-0006 · Cited by 386
Episodic Angioedema Associated with Eosinophilia
Gleich, G. J., Schroeter, A. L., Marcoux, J. P., Sachs, M. I., O'Connell, E. J., & Kohler, P. F. (1984) · New England Journal of Medicine · doi:10.1056/nejm198406213102501 · Cited by 363
Approaches to the treatment of hypereosinophilic syndromes: A workshop summary report
Klion, A. D., Bochner, B. S., Gleich, G. J., Nutman, T. B., Rothenberg, M. E., Simon, H.-U., Wechsler, M. E., Weller, P. F., & the Hypereosinophilic Syndromes Working Group (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.02.042 · Cited by 342
Biology of Platelet-Derived Growth Factor and Its Involvement in Disease
Alvarez, R. H., Kantarjian, H. M., & Cortes, J. E. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.9.1241 · Cited by 334
The cardiovascular manifestations of the hypereosinophilic syndrome
Parrillo, J. E., Borer, J. S., Henry, W. L., Wolff, S. M., & Fauci, A. S. (1979) · The American Journal of Medicine · doi:10.1016/0002-9343(79)90227-4 · Cited by 314
Self-citationEosinophilia: secondary, clonal and idiopathic
Tefferi, A., Patnaik, M. M., & Pardanani, A. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06038.x · Cited by 298
How I treat hypereosinophilic syndromes
Klion, A. D. (2015) · Blood · doi:10.1182/blood-2014-11-551614 · Cited by 296
Gotlib, J., Cools, J., Malone, J. M., Schrier, S. L., Gilliland, D. G., & Coutré, S. E. (2004) · Blood · doi:10.1182/blood-2003-06-1824 · Cited by 290
Cardiac Localization of Eosinophil-Granule Major Basic Protein in Acute Necrotizing Myocarditis
deMello, D. E., Liapis, H., Jureidini, S., Nouri, S., Kephart, G. M., & Gleich, G. J. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011293232207 · Cited by 122
Heart Disease and the Eosinophil
Parrillo, J. E. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011293232211 · Cited by 83
Self-citation
Metadata
- Authors
- PARRILLO, J. E., FAUCI, A. S., & WOLFF, S. M.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 1978-08-01
- Volume
- 89
- Issue
- 2
- Pages
- 167-172
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2044327033
- Cited by
- 259
- References
- 9
- FWCI
- 9.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.